RELIEF THERAPEUTICS N - Weekly - Technical analysis published on 03/07/2023 (GMT)
- 189
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Weekly
- - Analysis generated on
- Status : TARGET REACHED
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Trends
Short term:
Strongly bearish
Underlying:
Strongly bearish
Technical indicators
22%
67%
11%
My opinion
Bearish under 0.0243 CHF
My targets
0.0192 CHF (-14.80%)
0.0148 CHF (-34.09%)
My analysis
All elements being clearly bearish, it would be possible for traders to trade only short positions (for sale) on RELIEF THERAPEUTICS N as long as the price remains well below 0.0243 CHF. The sellers' bearish objective is set at 0.0192 CHF. A bearish break of this support would revive the bearish momentum. The sellers could then target the support located at 0.0148 CHF. In case of crossing, the next objective would be the support located at 0.0097 CHF. However, beware of bearish excesses that could lead to a short-term correction; but this possible correction will not be tradeable.
Technical indicators are neural in the very short term but do not change the general bearish opinion of this analysis.
Force
0
10
7.5
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by smich71. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The RELIEF THERAPEUTICS N price is 0.0225 CHF. Over 5 days, this instrument lost -4.26% and was traded between 0.0217 CHF and 0.0236 CHF over the period. The price is currently at +3.69% from its lowest point and -4.66% from its highest point.0.0217
0.0236
0.0225
The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by RELIEF THERAPEUTICS N:
Technical
Technical analysis of RELIEF THERAPEUTICS N in Weekly shows a overall strongly bearish trend. 92.86% of the signals given by moving averages are bearish. The overall trend is supported by the strong bearish signals from short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
But beware of excesses. The Central Indicators scanner currently detects this:
RSI indicator is oversold : under 30
Type : Neutral
Timeframe : Weekly
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : Weekly
Previous candle closed under Bollinger bands
Type : Neutral
Timeframe : Weekly
MACD crosses DOWN its Moving Average
Type : Bearish
Timeframe : Weekly
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S1
R1
R2
R3
Price
| S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|
| ProTrendLines | 0.0219 | 0.0225 | 0.1080 | 0.2300 | 0.5200 |
| Change (%) | -2.67% | - | +380.00% | +922.22% | +2,211.11% |
| Change | -0.0006 | - | +0.0855 | +0.2075 | +0.4975 |
| Level | Major | - | Minor | Intermediate | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0209 | 0.0215 | 0.0225 | 0.0231 | 0.0241 | 0.0247 | 0.0257 |
| Camarilla | 0.0232 | 0.0233 | 0.0235 | 0.0236 | 0.0238 | 0.0239 | 0.0240 |
| Woodie | 0.0212 | 0.0216 | 0.0228 | 0.0232 | 0.0244 | 0.0248 | 0.0260 |
| Fibonacci | 0.0215 | 0.0221 | 0.0225 | 0.0231 | 0.0237 | 0.0241 | 0.0247 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0166 | 0.0186 | 0.0206 | 0.0226 | 0.0246 | 0.0266 | 0.0286 |
| Camarilla | 0.0215 | 0.0219 | 0.0222 | 0.0226 | 0.0230 | 0.0233 | 0.0237 |
| Woodie | 0.0166 | 0.0186 | 0.0206 | 0.0226 | 0.0246 | 0.0266 | 0.0286 |
| Fibonacci | 0.0186 | 0.0201 | 0.0211 | 0.0226 | 0.0241 | 0.0251 | 0.0266 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0097 | 0.0148 | 0.0192 | 0.0243 | 0.0287 | 0.0338 | 0.0382 |
| Camarilla | 0.0209 | 0.0218 | 0.0226 | 0.0235 | 0.0244 | 0.0252 | 0.0261 |
| Woodie | 0.0093 | 0.0146 | 0.0188 | 0.0241 | 0.0283 | 0.0336 | 0.0378 |
| Fibonacci | 0.0148 | 0.0185 | 0.0207 | 0.0243 | 0.0280 | 0.0302 | 0.0338 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 28.44 | |
| MACD (12,26,9): | -0.0033 | |
| Directional Movement: | -14.0791 | |
| AROON (14): | -57.1429 | |
| DEMA (21): | 0.0231 | |
| Parabolic SAR (0,02-0,02-0,2): | 0.0319 | |
| Elder Ray (13): | -0.0040 | |
| Super Trend (3,10): | 0.0318 | |
| Zig ZAG (10): | 0.0228 | |
| VORTEX (21): | 0.8976 | |
| Stochastique (14,3,5): | 22.56 | |
| TEMA (21): | 0.0262 | |
| Williams %R (14): | -78.46 | |
| Chande Momentum Oscillator (20): | -0.0066 | |
| Repulse (5,40,3): | -2.4661 | |
| ROCnROLL: | 2 | |
| TRIX (15,9): | -1.2134 | |
| Courbe Coppock: | 26.66 |
| MA7: | 0.0230 | |
| MA20: | 0.0241 | |
| MA50: | 0.0275 | |
| MA100: | 0.0281 | |
| MAexp7: | 0.0249 | |
| MAexp20: | 0.0278 | |
| MAexp50: | 0.0432 | |
| MAexp100: | 0.0745 | |
| Price / MA7: | -2.17% | |
| Price / MA20: | -6.64% | |
| Price / MA50: | -18.18% | |
| Price / MA100: | -19.93% | |
| Price / MAexp7: | -9.64% | |
| Price / MAexp20: | -19.06% | |
| Price / MAexp50: | -47.92% | |
| Price / MAexp100: | -69.80% |
Quotes :
-
15 min delayed data
-
Switzerland SWX Stocks
News
The latest news and videos published on RELIEF THERAPEUTICS N at the time of the analysis were as follows:
- Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
- Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
- Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
- Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
- Relief Therapeutics Provides an Update on its Financing Strategy
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis RELIEF THERAPEUTICS N - Weekly